Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

NCT02726542 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02726542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
May 3, 2017
Completion date
April 2, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld